Holy Smokes —These are FIRE 🔥

Top 5 Small-Cap Swing Trades to Crush It in October 2025

October 15, 2025 | By The Swing Trader

Grok assisted blog accuracy not guaranteed

We’re riding high after nailing WULF, WOLF, OPEN, and GNPX—early entries, fat gains, and market-beating moves. Could we have held for more? Maybe. But getting ahead of the game like that? Pure adrenaline. Now, with small-caps coiling for breakouts amid trade war noise and sector rotations (AI, semis, bios), we’re back with five high-probability swing setups for 30-60% base returns and 100%+ stretch potential. Pulled from X chatter (@TigerLineTrades, @stockplaymaker1, @BioRunUp) and real-time market data (Polygon, 90-day OHLCV), these low-float runners are primed for the next 1-5 days. Red market days like today? Perfect for entries. Let’s stack more wins!

October’s Hottest Swing Setups

Ticker Entry Range Target 1 (30-60%) Stretch Target (100%+) Stop Loss Timeframe Probability
$RR (Richtech Robotics) $5.80 - $6.20 $8.00 (35%) $11.00+ (80%+) $5.50 2-4 days 77%
$SOAR (Volato Group) $3.00 - $3.20 $4.30 (38%) $6.50+ (105%+) $2.80 1-3 days 70%
$VERI (Veritone) $7.80 - $8.20 $11.00 (37%) $16.00+ (100%+) $7.40 3-5 days 75%
$NVTS (Navitas Semiconductor) $14.50 - $15.00 $20.50 (37%) $30.00+ (100%+) $13.80 2-4 days 80%
$IXHL (Incannex Healthcare) $0.36 - $0.39 $0.54 (42%) $0.80+ (110%+) $0.34 1-3 days 68%

Setup & Catalyst Details

$RR (Richtech Robotics)

Multi-week base breakout on rare earth/mining rotation. X buzz: @PlayBookTrades calls golden cross, @StockOptionCole sees 50-80% rally. Catalyst: Trump’s 100% tariff threat boosts U.S. miners (CNBC/Reuters). Data: +235% since July ($2.01-$6.16), RSI 62, vol 50M+ on spikes.

$SOAR (Volato Group)

Bull flag post-merger gap. X buzz: @RisenFit flags M2i Global pivot to U.S. minerals reserve. Catalyst: Q2 net $3.6M, Q3 aligns, seaplane expansion. Data: +88% since July ($1.68-$3.16), RSI 58, vol 3M+ today.

$VERI (Veritone)

Double bottom reversal on AI contract wins. X buzz: @zohmbastic praises "unstructured AI data leader." Catalyst: $40M pipeline, Q3 rev $28.5-28.7M (+30% YoY). Data: +290% since July ($2.15-$8.39), RSI 68, vol 46M today.

$NVTS (Navitas Semiconductor)

Falling wedge breakout on GaN/SiC for AI/EV. X buzz: @StockSavvyShay (+55%), @rip_trader (+104%). Catalyst: NVDA 800VDC rack demand, Q3 previews Nov 3. Data: +141% since July ($6.27-$15.16), RSI 72, vol 148M today.

$IXHL (Incannex Healthcare)

Support pullback in bio rally. X buzz: @RiskRebelGrace sees momentum. Catalyst: Phase 2 IHL-42X OSA data leak, 347M share dilution scrubbed. Data: -18% since July ($0.37-$0.38), RSI 45, vol 20M avg.

Risk Management & Execution

These are volatile small-caps—low floats, high beta. Scale in on dips (buy 50% at entry, 50% on VWAP hold). Trail stops to breakeven after +10%, lock 50-60% at Target 1, let runners chase stretches. Max risk: 1.5-2% per trade. $RR/$NVTS could pop harder on China tariff news; $IXHL needs tight stops for bio whips. Watch X for real-time updates—@TigerLineTrades and @stockplaymaker1 are dropping heat daily.

Disclaimer

Trading is high risk. Past performance isn’t a guarantee, and these setups are based on technicals, X sentiment, and market data as of Oct 15, 2025. Do your own research, manage risk, and consult a financial advisor. We’re not liable for losses—trade smart!

Which setup are you jumping on? Drop your thoughts in the comments or follow for daily trade ideas!

Follow for More

Comments

Post a Comment

Popular posts from this blog

WULF Moderate Risk High Potential For Return

TeraWulf Inc. (WULF): A Swing Trading Opportunity with 30% Chance of 60% Return Date: July 29, 2025 | Stock Price: $5.19 | Market: NASDAQ Grok assisted blog accuracy not guaranteed  Research suggests TeraWulf Inc. (WULF) offers a compelling swing trading opportunity, with a 30% chance of achieving a 60% return , potentially reaching $8.30 from its current price of $5.19. This potential is driven by upcoming earnings, Bitcoin market trends, and the company’s strategic pivot to high-performance computing (HPC) hosting. Here’s a detailed breakdown for swing traders looking to capitalize on this high-risk, high-reward stock. Stock Overview TeraWulf Inc., a Technology Services company in the Data Processing Services sector, is a Bitcoin miner transitioning to HPC hosting for AI and cloud computing. Trading at $5.19 as of 10:35 AM CDT on July 29, 2025, WULF has a 52-week range of $2.06–$9.30, reflecting its vol...
Read more

ZKIN I'm Inn

Is ZKIN the Next Big Swing Trade Opportunity? Technical Analysis and Trade Plan (I generated this blog post from the Sleep Inn Oklahoma City Bricktown with the help of Grok accuracy is not guaranteed) ZK International Group Co., Ltd. (NASDAQ: ZKIN) is catching the eye of swing traders with its recent price action, high volatility, and potential catalysts. Priced at $1.88 (as of August 19, 2025), ZKIN offers a compelling setup for traders looking to capitalize on short-term price swings. This blog post dives into the technical and fundamental factors driving this opportunity, outlines two trade setups, and provides a step-by-step guide to execute them. Click the dropdowns for deeper insights! Why ZKIN? The Opportunity at a Glance ZKIN, a small-cap stock with a $9.71M market cap, operates in the steel and cryptocurrency sectors, with recent developments like a Shenzhen Gas Group contract and the upcoming xSigma Wallet launch fueling optimism. ...
Read more

INHD Inhibikase Therapeutics

INHD Swing Trade Setup: High-Reward Opportunity for Aggressive Traders Posted on August 29, 2025 Grock assisted log accuracy not guaranteed Hey traders! If you’re looking for a high-octane swing trade with big potential, Inhibikase Therapeutics (INHD) might be your next play. Inspired by momentum-driven traders like @TigerLineTrades and recent buzz on X (like @timothysykes calling out INHD’s spike from $2.60s to $3.80s), I’ve put together an aggressive swing trade setup targeting 30–90% returns in just 1–3 days. Here’s the breakdown, complete with entry points, exit targets, and key indicators to watch. Let’s dive in! Why INHD? The Setup Explained INHD, a clinical-stage biotech, is making waves with its work on Parkinson’s and pulmonary arterial hypertension (PAH). Recent catalysts, like FDA approval for a late-stage PAH trial and $275M in financing (August 2025), have fueled volatility—perfect for swing traders chasing quick gains. With a recent ...
Read more